Patrick Pedonti
Analyst · Andrew Schmidt with Citi. Your line is open
Thanks. Results for the first quarter were GAAP revenues of $1.327 million; GAAP net income of $126 million, and GAAP diluted earnings per share of $0.49. Adjusted revenues were $1.634 billion. Adjusted revenues were up 5.2%. Adjusted operating income decreased 1.1% and adjusted diluted EPS was $1.11, 11.2% decrease over Q1 2022 due to the impact of higher interest rates on our debt. Adjusted revenue increased $67.2 million or 5.2%. Our acquisitions contributed $64 million. Foreign exchange had an unfavorable impact of $19.9 million or 1.5%. Adjusted organic revenue increase on a constant currency basis was 1.9%. We had strength in several product lines, including alternatives against transfer agency services business and institutional investment management business. Adjusted operating income for the quarter was $493 million, a decrease of $5.7 million or 1.1% from the first quarter of 2022. Adjusted operating margins were 36.2% in the first quarter compared to 38.5% in the first quarter of 2022. Excluding acquisitions, expenses increased 5% on a constant currency basis. Acquisitions added $52 million in expenses and foreign currency decreased cost by $19.6 million. Our cost structure has been impacted by general inflation, wage inflation and increase in business travel compared to 2022. Adjusted EBITDA was $509 million or 37.3% of adjusted revenue, a decrease of $5.9 million from Q2 2022. Net interest expense for the quarter was $111.9 million, an increase of $62.6 million or 127% from Q1 2022. In Q1 2023, net interest expense includes $3.5 million of noncash amortized financing costs and OID. The average interest rate in the quarter for the amended credit facility, including our senior notes, was 6.21% compared to 3.11% in the first quarter of 2022. We recorded a GAAP tax provision of $52.5 million or 29% of pre-tax income. Adjusted net income was $284.4 million and adjusted EPS was $1.11, and the effective tax rate used for adjusted net income was 26%. Diluted shares increased to 257 million from 256.4 million in Q4. The higher average stock price partially -- was partially offset by share repurchases during the quarter. On cash flow and balance sheet. We ended the first quarter with $433.3 million of cash and cash equivalents and $7.1 billion of gross debt. SS&C's net debt, which excludes cash and cash equivalents of $130.2 million that are held at DomaniRx, was $6.8 billion as of March 31st. Operating cash flow for the three months was $254.8 million, $1.3 million increase from the same period in 2022. Some highlights on cash flow for the three months. We bought back treasury stock for $134.7 million and repurchased 2.3 million shares at an average price of $59.19. In July 2022, the Board authorized the new stock repurchase program of up to $1 billion in stock buybacks. Program to date, treasury stock buybacks are $439.9 million for purchases of 7.8 million shares at an average price of $56.34. Net debt payments in the quarter were $44.6 million. And we paid total of interest of $138 million in the quarter compared to $74.2 million in 2022. On income taxes, in the quarter, we paid $20.9 million compared to $42 million in the first quarter of 2022. Our accounts receivable DSO was 53.5 days as of March 31st compared to 52.3 days as of March -- as of December 2022 and 52.7 days as of March 2022. Capital expenditures and capitalized software was $53.1 million or 3.9% of adjusted revenue for the quarter. Spending was predominantly for capitalized software to investment in research and development and IT infrastructure. Based on our net debt of approximately $6.8 billion, our total leverage was 3.38 times and our secured leverage was 2.39 times as of March 31st. On outlook for the year, first, I'll cover a few assumptions. We'll continue to focus on client service, and we expect retention rates to continue in the range of most recent results. We have assumed foreign currency exchange will be at current levels for the remainder of the year. And as a result, organic growth for the year will be in the range of 2% to 6%, and adjusted organic growth for Q2 will be in the range of 0.5% to 3.5%. We have assumed interest rates will increase in additional in the range of 35 to 50 bps through the remainder of the year compared to the average rate in the first quarter. We'll continue to manage our expenses during the period by controlling variable expenses and increased productivity to improve our operating margins. We'll continue to allocate free cash flow to both debt pay down and stock buybacks, and we continue to expect the adjusted tax rate to be about 26%. So, for the second quarter of 2023, we expect revenue in the range of $1.3345 billion to $1.3745 billion. Adjusted net income in the range of $276.5 million to $293 million, and diluted shares in the range of $256.5 million to $257.5 million. And for the full year, we expect revenue in the range of $5.455 billion to $5.655 billion. Adjusted net income in the range of $1.190 billion to $1.285 billion and diluted shares in the range of 255 million to 258.5 million. And on cash from operating activities, we expect that to be in the range of $1.275 billion to $1.375 billion. And I'll turn it back over to Bill for final comments.